Sebelipase alfa

Kanuma Concentrate for Solution for Infusion 2 MG/ML

2 mg/ml infusion, solution concentrateSingaporeAuthorisedAuthorised 30 Sept 2025

In other countries

The same active substances on other registers, the same brand first.

KanumaCanada · 2 MG / ML · Solution · Alexion Pharma GMBHSame brand
Kanuma 2 MG/ML Concentrado Para Solucion Para PerfusionSpain · 20 mg · concentrado para solución para perfusión · Alexion Europe SasSame brand
KanumaEuropean Union · Alexion Europe SASSame brand
KanumaCroatiaSame brand
KanumaItaly · Concentrato per soluzione per infusione · Alexion Europe S.A.S.Same brand
Kanuma 2 mg/ml, concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Alexion Europe SASSame brand
KanumaSaudi Arabia · Patheon Italia S.P.A.Same brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sebelipase alfa

Kanuma Concentrate for Solution for Infusion 2 MG/ML

2 mg/ml infusion, solution concentrateSingaporeAuthorisedAuthorised 30 Sept 2025

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

KanumaUnited States · 20MG/10ML · injectable · Alexion Pharm

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence 1.0 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Sebelipase alfa
Strength: 2 mg/ml
Dosage form: infusion, solution concentrate
Route: intravenous
Register: Singapore (HSA)
Status: Authorised
Status in the register: Registered
Authorised: 30 Sept 2025
Registration: SIN17346P
Marketing authorisation holder: Astrazeneca Singapore Pte LTD
Manufacturer: Alexion Pharma International Operations Limited (AAMF site), IRELAND
ATC code: A16AB14
Group: Alimentary tract and metabolism
Supply: Prescription Only